Active Funding Opportunities and Notices for NICHD
NICHD publishes and participates in various notices of funding opportunities (NOFOs) and NIH Guide Notices (NOTs) to support research and training activities.
NOTs and Active NOFOs for NICHD
Please note: the following are sorted by date, from most recent to older. Select a table heading to change how to sort the information.
Number | Exp. Date | Activity Code(s) Sort ascending | Title |
---|---|---|---|
NOT-HD-20-023 | January 1, 2027 | Notice to Extend the Application Due Date and Expiration Date for RFA-HD-21-016 "Collaborative Pediatric Critical Care Research Network (PL1) (Clinical Trial Required)" | |
NOT-MH-20-062 | January 1, 2027 | Notice of Intent to Publish a Funding Opportunity Announcement for "BRAIN Initiative Fellows: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)" | |
NOT-HD-20-018 | January 1, 2027 | Notice of Availability of National Childrens Study (NCS) Vanguard Biological and Environmental Sample Materials | |
NOT-HD-20-017 | January 1, 2027 | Notice of NICHD Participation in NOT-EB-20-012 "Notice of Change in Application Due Date for PAR-19-215 Due to Public Health Emergency for United States Coronavirus Disease 2019 (COVID-19)" | |
NOT-HD-20-009 | January 1, 2027 | Notice of Interest in Advancing Research on FMR1-Associated Conditions | |
NOT-MH-21-045 | January 1, 2027 | Notice of Extension to PA-18-399, "Research on Autism Spectrum Disorders (R03-Clinical Trial Optional)" | |
NOT-MH-21-046 | January 1, 2027 | Notice of Extension to PA-18-400, "Research on Autism Spectrum Disorders (R21-Clinical Trial Optional)" | |
NOT-MH-21-047 | January 1, 2027 | Notice of Extension to PA-18-401, "Research on Autism Spectrum Disorders (R01-Clinical Trial Optional)" | |
NOT-HD-20-038 | January 1, 2027 | Notice of Extension of the Expiration Date for PAR-18-885 Novel Approaches to Safe, Non-Invasive, Real Time Assessment of Human Placenta Development and Function Across Pregnancy (R21 - Clinical Trial Not Allowed) | |
NOT-HD-20-037 | January 1, 2027 | Notice of Extension of the Expiration Date for PAR-18-884 Novel Approaches to Safe, Non-Invasive, Real Time Assessment of Human Placenta Development and Function Across Pregnancy (R01 - Clinical Trial Not Allowed) | |
NOT-OD-21-032 | January 1, 2027 | Notice Extending Expiration Date and Adding Receipt Date for PAR-18-324: Testing Interventions for Health-Enhancing Physical Activity (R01 - Clinical Trial Optional) | |
NOT-OD-21-034 | January 1, 2027 | Notice of Intent to Reissue Funding Opportunity Announcements "Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01)" to Permit Resubmissions | |
NOT-OD-21-011 | January 1, 2027 | Notice of NIH Participation in Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science | |
NOT-HD-20-036 | January 1, 2027 | NICHD Data and Safety Monitoring Guidelines for Extramural Clinical Trials and Clinical Research | |
NOT-HD-20-040 | January 1, 2027 | Notice of NICHD Participation on PA-20-200 "NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)" | |
NOT-HD-20-041 | January 1, 2027 | Notice of NICHD Participation on PA-20-194 "NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)" | |
NOT-HD-20-042 | January 1, 2027 | Notice of NICHD Participation on PA-20-195 "NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)" | |
NOT-HD-20-043 | January 1, 2027 | Notice to Extend Expiration Date for PAR-19-133 "Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Required)" | |
NOT-NS-24-080 | January 1, 2027 | Request for Information (RFI): BRAIN Initiative: Opportunities and Challenges for Coordinated Neural Stimulating and Recording Efforts to Advance Understanding of Human Neuroscience and Behavior | |
NOT-HD-20-035 | January 1, 2027 | NICHD Adverse Event, Unanticipated Problem, and Serious Adverse Event Reporting Guidance |